» Articles » PMID: 29942092

Single-cell Profiling of Breast Cancer T Cells Reveals a Tissue-resident Memory Subset Associated with Improved Prognosis

Abstract

The quantity of tumor-infiltrating lymphocytes (TILs) in breast cancer (BC) is a robust prognostic factor for improved patient survival, particularly in triple-negative and HER2-overexpressing BC subtypes. Although T cells are the predominant TIL population, the relationship between quantitative and qualitative differences in T cell subpopulations and patient prognosis remains unknown. We performed single-cell RNA sequencing (scRNA-seq) of 6,311 T cells isolated from human BCs and show that significant heterogeneity exists in the infiltrating T cell population. We demonstrate that BCs with a high number of TILs contained CD8 T cells with features of tissue-resident memory T (T) cell differentiation and that these CD8 T cells expressed high levels of immune checkpoint molecules and effector proteins. A CD8 T gene signature developed from the scRNA-seq data was significantly associated with improved patient survival in early-stage triple-negative breast cancer (TNBC) and provided better prognostication than CD8 expression alone. Our data suggest that CD8 T cells contribute to BC immunosurveillance and are the key targets of modulation by immune checkpoint inhibition. Further understanding of the development, maintenance and regulation of T cells will be crucial for successful immunotherapeutic development in BC.

Citing Articles

Analysis of single-cell and spatial transcriptomics in TNBC cell-cell interactions.

Xin Y, Ma Q, Deng Q, Wang T, Wang D, Wang G Front Immunol. 2025; 16:1521388.

PMID: 40079015 PMC: 11897037. DOI: 10.3389/fimmu.2025.1521388.


Revolutionary Cancer Therapy for Personalization and Improved Efficacy: Strategies to Overcome Resistance to Immune Checkpoint Inhibitor Therapy.

Almawash S Cancers (Basel). 2025; 17(5).

PMID: 40075727 PMC: 11899125. DOI: 10.3390/cancers17050880.


Tissue-Resident Memory CD8+ T Cells: Differentiation, Phenotypic Heterogeneity, Biological Function, Disease, and Therapy.

Xu L, Ye L, Huang Q MedComm (2020). 2025; 6(3):e70132.

PMID: 40066223 PMC: 11892159. DOI: 10.1002/mco2.70132.


Canine, Feline, and Murine Mammary Tumors as a Model for Translational Research in Breast Cancer.

Cassali G, Nakagaki K, Salvi M, Dos Reys M, Rocha M, de Campos C Vet Sci. 2025; 12(2).

PMID: 40005948 PMC: 11860833. DOI: 10.3390/vetsci12020189.


Advancing Immunotherapy in Pancreatic Cancer: A Brief Review of Emerging Adoptive Cell Therapies.

Sherpally D, Manne A Cancers (Basel). 2025; 17(4).

PMID: 40002184 PMC: 11853216. DOI: 10.3390/cancers17040589.